A comparison of characteristics and outcomes of opioid-dependent patients initiating office-based buprenorphine or methadone maintenance treatment

Substance Abuse

Volumn 35, Issue 2, 2014, Pages 122-126

  Fingerhood, Michael I ^a   King, Van L ^a   Brooner, Robert K ^a   Rastegar, Darius A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Buprenorphine; methadone; opioid dependent; treatment

Indexed keywords

BUPRENORPHINE; METHADONE; NARCOTIC AGENT; NARCOTIC ANTAGONIST;

ADULT; COMPARATIVE STUDY; FEMALE; HEALTH SERVICE; HUMAN; INTERNAL MEDICINE; MALE; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; RETROSPECTIVE STUDY; SOCIOECONOMICS; TIME; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; BUPRENORPHINE; FEMALE; HUMANS; INTERNAL MEDICINE; MALE; METHADONE; NARCOTIC ANTAGONISTS; NARCOTICS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; STUDENT HEALTH SERVICES; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84901236908     PISSN: 08897077     EISSN: 15470164     Source Type: Journal    
DOI: 10.1080/08897077.2013.819828     Document Type: Article

References (14)

1. Nelson LS, Perrone J. Curbing the opioid epidemic in the United States: the risk evaluation and mitigation strategy (REMS). JAMA. 2012;308:457-458.
2. Substance Abuse and Mental Health Services Administration. Results From the 2010 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2011. NSDUH Series H-41, HHS Publication No. (SMA) 11-4658.
3. Centers for Disease Control and Prevention. Vital signs: overdoses of prescription opioid pain relievers-United States, 1999-2008.MMWR Morb Mort Wkly Rep. 2011;60:1487-1492.
4. Bart G. Maintenance medication for opiate addiction: the foundation of recovery. J Addict Dis. 2012;31:207-225.
5. Barnett PG, Rodgers JH, Bloch DA. A meta-analysis comparing buprenorphine to methadone for treatment of opiate dependence. Addiction. 2001:96:683-690.
6. Castells X, Kosten T, Capella D, et al. Efficacy of opiate maintenance therapy and adjunctive interventions for opioid dependence with comorbid cocaine use disorders: a systematic review and meta-analysis of controlled clinical trials. The American Journal of Drug and Alcohol Abuse. 2009;35:339-349.
7. Connock M, Juarez-Garcia A, Jowett S, et al. Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Health Technol Assess. 2007;11:1-171.
8. Mattick RP, Kimber J, Breen C, Davoli M. Buprenorphine maintenance verse placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2008;(2):CD002207.
9. Curcio F, Franco T, Topa M, et al. Buprenorphine/naloxone verse methadone in opioid dependence: a longitudinal survey. Eur Rev Pharmacol Sci. 2011;15:871-874.
10. Marsch LA, Stephens MAC, Mudric T, Strain EC, Bigelow GE, Johnson RE. Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence. Experimental and Clinical Psychopharmacology. 2005;13:293-302.
11. Doran C, Shanahan M, Mattick RP, Ali R, White J, Bell J. Buprenorphine verse methadone maintenance: a cost-effectiveness analysis. Drug Alcohol Depend. 2003;71:295-302.
12. Schackman BR, Leff JA, Polsky D, Moore BA, Fiellin DA. Costeffectiveness of long-term outpatient buprenorphine-naloxone treatment for opioid dependence in primary care. J Gen Int Med. 2011;27:669-676.
13. Tetrault JM, Moore BA, Barry DT, et al. Brief versus extended counseling along with buprenorphine/naloxone for HIV-infected opioid dependent patients. J Subst Abuse Treat. 2012;43:433-439.
14. Weiss RD, Potter JS, Fiellin DA, et al. Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for opioid dependence: a 2-phase randomized controlled trial. Arch Gen Psychol. 2011;68:1238-1246.